ET-traps
ET-traps
  • HOME
  • ABOUT US
  • NEWS & AWARDS
  • TEAM
  • SCIENTIFIC PUBLICATIONS
  • CLINICAL APPLICATIONS
  • More
    • HOME
    • ABOUT US
    • NEWS & AWARDS
    • TEAM
    • SCIENTIFIC PUBLICATIONS
    • CLINICAL APPLICATIONS
  • HOME
  • ABOUT US
  • NEWS & AWARDS
  • TEAM
  • SCIENTIFIC PUBLICATIONS
  • CLINICAL APPLICATIONS

Welcome to ET-traps Limited

Welcome to ET-traps LimitedWelcome to ET-traps LimitedWelcome to ET-traps Limited

Novel therapeutics 

Contact Us

Welcome to ET-traps Limited

Welcome to ET-traps LimitedWelcome to ET-traps LimitedWelcome to ET-traps Limited

Novel therapeutics 

Contact Us

What We Do

Commitment to Innovation

ET-traps is a novel therapeutic that targets pathologically elevated endothelin-1 levels in the body, bringing endothelin-1 and various markers of heart and kidney function back to non-disease levels without side effects.

Drug Development

We have discovered a potent therapy for chronic kidney disease, cardiovascular disease, and other diseases associated with pathologically elevated ET-1 levels such as diabetes and neurological disorders, with a low cost, low dosage drug with no side effects.


Copyright © 2022  ET-traps  Limited- All Rights Reserved.

  • ABOUT US
  • NEWS & AWARDS
  • TEAM
  • SCIENTIFIC PUBLICATIONS
  • CLINICAL APPLICATIONS
  • CONTACT